Home >Take Action >Current Clinical Trials

Current Studies

Visit: ClinicalTrials.gov

Find out: What is a clinical study?

How do I learn more about current open studies?

Below you will find a list of current studies. Clicking on the link will take you to the study summary, which will provide you with all the important details for each study

How do I participate in a study?

Each study summary provides a list of hospitals or clinics where the study is being run. Using the contact information provided, you may contact any of these facilities in order to request participation in a study.

Wegener’s Granulomatosis (WG)

• 5505: Longitudinal Protocol for Wegener's Granulomatosis and Microscopic Polyangiitis
• 5522: VCRC Multi-Center, Open-Label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener’s Granulomatosis (WG)

Microscopic Polyangiitis (MPA)

• 5505: Longitudinal Protocol for Wegener's Granulomatosis and Microscopic Polyangiitis

Churg-Strauss Syndrome (CSS)

• 5506: Longitudinal Protocol for Churg-Strauss Syndrome

Polyarteritis Nodosa (PAN)

• 5504: Longitudinal Protocol for Polyarteritis Nodosa

Takayasu's Arteritis (TAK)

• 5503: Longitudinal Protocol for Takayasu's Arteritis
• 5515: VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-Vessel Vasculitis (Takayasu's Arteritis):  Development as Clinical Trial Outcome Measures
• 5523: Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu’s Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis (AGATA)

Giant Cell (Temporal) Arteritis (GCA)

• 5502: Longitudinal Protocol for Giant Cell Arteritis
• 5523: Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu’s Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis (AGATA)

Please Note: The Rare Diseases Clinical Research Network will make every effort to enroll all the patients we can, but we cannot make any guarantees that we will be able to enroll everyone in a particular study who wants to participate.

This list was last updated on 1 May 2008

Home | Glossary | Frequently Asked Questions | Contact Web Master | Accessibility | Disclaimer | Site Map
Return to RDCRN Main Page